Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study

Authors: I Calcaterra, A Di Minno, M Gentile, M Tripaldella, A Buonaiuto, F Forte, M.D Di Taranto, C Giacobbe, G Iannuzzo, P.O.F Rubba, M.N.D Di Minno

Published: 2020-11-26

DOI: 10.1093/ehjci/ehaa946.3347

Source: Full article

Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study

Abstract